Gilles Kayem Selected Research

Placenta Accreta

1/2022	Conservative management or cesarean hysterectomy for placenta percreta? A subgroup analysis of the PACCRETA study is needed.
1/2022	Conservative management or cesarean hysterectomy for placenta accreta spectrum? Local resources and organization of care matter.
1/2022	Conservative management or cesarean hysterectomy for placenta accreta spectrum: the PACCRETA prospective study.
1/2022	Assessing conservative management vs cesarean hysterectomy for placenta accreta spectrum: the importance of comparing data collected at the same study period.
4/2021	Conservative approach: Intentional retention of the placenta.
12/2018	Conservative Management of Placenta Accreta Spectrum.
3/2018	FIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management.
1/2018	Placenta percreta is associated with more frequent severe maternal morbidity than placenta accreta.
10/2013	Management of placenta accreta.
11/2010	Fertility and pregnancy outcomes following conservative treatment for placenta accreta.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gilles Kayem Research Topics

Disease

15	Placenta Accreta 01/2022 - 09/2002
12	Rupture 01/2022 - 01/2005
8	Postpartum Hemorrhage 12/2022 - 01/2011
8	Hemorrhage 12/2022 - 03/2016
8	Infections 09/2021 - 01/2005
6	Premature Birth (Birth, Premature) 01/2022 - 01/2006
5	Chorioamnionitis 01/2022 - 12/2005
5	Premature Obstetric Labor (Premature Labor) 01/2022 - 01/2006
5	Spontaneous Abortion (Miscarriage) 01/2021 - 01/2016
4	Preterm Premature Rupture of the Membranes 01/2022 - 05/2019
4	Habitual Abortion (Recurrent Miscarriage) 01/2021 - 01/2016
3	Endometritis 01/2022 - 09/2004
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2021
2	Uterine Rupture 01/2022 - 09/2013
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2022 - 04/2020
2	Necrotizing Enterocolitis 01/2022 - 12/2018
2	COVID-19 09/2021 - 09/2020
2	Infertility (Sterility) 01/2021 - 09/2020
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2020 - 03/2017
2	Abruptio Placentae (Placental Abruption) 05/2017 - 01/2017
2	Fetal Growth Retardation (Intrauterine Growth Retardation) 05/2017 - 01/2016
1	Acidosis 03/2022
1	Respiratory Insufficiency (Respiratory Failure) 03/2022
1	Asphyxia (Suffocation) 03/2022
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 03/2022
1	Perinatal Death 01/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022
1	Bronchopulmonary Dysplasia 01/2022
1	Sepsis (Septicemia) 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Neonatal Sepsis 01/2022
1	Brain Diseases (Brain Disorder) 01/2022
1	Pruritus (Itching) 04/2021
1	Intrahepatic Cholestasis of Pregnancy 04/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2021
1	Endometriosis 01/2021
1	Postpartum Depression (Post-Natal Depression) 01/2021
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2021

Drug/Important Bio-Agent (IBA)

7	Oxytocin (Pitocin)FDA LinkGeneric 07/2020 - 09/2013
5	Tranexamic Acid (AMCA)FDA Link 12/2022 - 03/2016
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 03/2017
5	SteroidsIBA 04/2021 - 01/2016
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2005
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 01/2017
3	Nifedipine (Adalat)FDA LinkGeneric 09/2021 - 03/2017
3	Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric 12/2018 - 01/2017
3	Interleukin-6 (Interleukin 6)IBA 04/2017 - 01/2005
3	Fibronectins (Fibronectin)IBA 03/2017 - 12/2005
3	C-Reactive ProteinIBA 04/2011 - 01/2005
2	Biological ProductsIBA 03/2022 - 09/2011
2	Antiphospholipid AntibodiesIBA 01/2022 - 01/2021
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021 - 01/2016
2	CytokinesIBA 01/2021 - 04/2017
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021 - 01/2016
2	Etanercept (Enbrel)FDA Link 01/2021 - 01/2016
2	Adalimumab (Humira)FDA Link 01/2021 - 01/2016
2	LE(2)IBA 05/2019 - 09/2013
2	ProstaglandinsIBA 05/2019 - 09/2013
2	atosibanIBA 01/2018 - 03/2017
1	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2022
1	Amoxicillin (Wymox)FDA LinkGeneric 01/2022
1	MacrolidesIBA 01/2022
1	Antinuclear AntibodiesIBA 01/2022
1	Third Generation CephalosporinsIBA 01/2022
1	Immunoglobulin G (IgG)IBA 09/2021
1	Azathioprine (Imuran)FDA LinkGeneric 04/2021
1	Bile Acids and Salts (Bile Acids)IBA 04/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 04/2021
1	AutoantibodiesIBA 01/2021
1	Tuberculin (PPD)IBA 01/2021
1	Infliximab (Remicade)FDA Link 01/2021
1	Betamethasone (Celestone)FDA Link 11/2020
1	Oxygen (Dioxygen)IBA 09/2020
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 09/2020
1	phospholipid emulsion soybean oil (Intralipid)IBA 09/2020
1	carbetocinIBA 07/2020
1	AntibodiesIBA 04/2020
1	AminoglycosidesIBA 05/2019
1	beta-LactamsIBA 05/2019
1	Tumor Necrosis Factor InhibitorsIBA 05/2019

Therapy/Procedure

14	Conservative Treatment 01/2022 - 09/2002
11	Hysterectomy 01/2022 - 09/2004
10	Therapeutics 01/2022 - 01/2017
5	Tocolysis 09/2021 - 01/2017
4	Blood Transfusion (Blood Transfusions) 12/2022 - 09/2004
3	Immunomodulation 01/2021 - 01/2016
3	Critical Care (Surgical Intensive Care) 01/2018 - 09/2004
2	Pessaries 01/2022 - 03/2017
2	Ambulatory Care (Outpatient Care) 12/2019 - 09/2018
2	Induced Labor 05/2019 - 09/2013
2	Prenatal Care (Care, Prenatal) 11/2017 - 01/2017
2	Cesarean Section (Caesarean Section) 05/2017 - 06/2008
1	Nutritional Support (Artificial Feeding) 03/2022
1	Antibiotic Prophylaxis 01/2022
1	Contraindications 01/2022
1	Ligation 01/2021
1	Artificial Respiration (Mechanical Ventilation) 09/2020
1	Noninvasive Ventilation 09/2020
1	Extracorporeal Membrane Oxygenation 09/2020
1	Intravenous Administration 05/2019